Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial.
Öcal O, Rössler D, Gasbarrini A, Berg T, Klümpen HJ, Bargellini I, Peynircioglu B, van Delden O, Schulz C, Schütte K, Iezzi R, Pech M, Malfertheiner P, Sangro B, Ricke J, Seidensticker M.
Öcal O, et al. Among authors: pech m.
J Cancer Res Clin Oncol. 2022 Sep;148(9):2487-2496. doi: 10.1007/s00432-021-03803-3. Epub 2021 Sep 20.
J Cancer Res Clin Oncol. 2022.
PMID: 34541612
Free PMC article.
Clinical Trial.